Organic Chemistry TRIZ Cases

This case uses an iodoalkyl compound with platinum, alcohol, and controlled CO/H2 conditions to improve acetal yield from olefins.

This case uses asymmetric hydrogenation and palladium coupling to make a CaSR modulator with scalable stereochemical control.

Direct esterification and aminolysis create diverse urea (meth)acrylates for anhydrous coatings with improved adhesion and scrub resistance.

This case uses benzimidazol-1,2-yl amides to selectively activate Kv7.2/7.3 channels and reduce effects linked to broader Kv7 modulation.

A high-index middle hole transport layer addresses weak LED emission efficiency by improving light extraction across the stack.

This case uses substituted quinoxalines to form covalent FGFR bonds, improving selectivity against resistance mutations.

Disubstituted alkyne derivatives target MCT1 and MCT4 together to limit lactate transport and sustain intracellular pH.

This case shows how DK6-1 structural changes balance mutant HIV-1 activity, water solubility, bioavailability, and toxicity.

Selective oxidants reduce sulfur by-product odor while preserving monothiocarbonates.

This case combines C10-C14 isophthalates to address high viscosity, slow absorption, migration, and stress resistance in resin plasticizers.

Substituted coumarin labels absorb at 450–460 nm, improving spectral separation and photo-stability for accurate multiplex sequencing.

Zinc-mediated dehalogenation creates a 3-cyanopyrrole intermediate for shorter, lower-cost sulfonylpyrrole production.

Sequential reagent treatment and simple purification support kilogram-scale pyridine production with less processing time and material loss.

This engineering case shows how a formula-based compound improves charge transport and light emission efficiency in organic EL elements.

Novel 6-fused heteroaryldihydropyrimidines target HBV capsid function to disrupt viral replication and nuclear translocation.

This ruxolitinib process reduces reliance on laborious chromatography and chiral resolution through targeted salt purification.

A releasable trans-cyclooctene linker enables rapid radionuclide cleavage, supporting repeat imaging with lower radiotoxicity.

This case uses salicylamine analogs to trap gamma-ketoaldehydes while preserving COX activity and prostaglandin production.

O-ethyl and methyl mercapto intermediates support thiobenzimidazole derivatives that inhibit tubulin polymerization and induce apoptosis.

Electron-accepting and donating units help the polymer retain charge mobility while stretched for flexible and wearable electronics.

A copolymer with sulfate or sulfonate groups improves conductivity and peel strength without ionic liquids or drying out.

A fluorene-based resin targets UV-A and UV-B while limiting bleed-out, whitening, embrittlement, and yellow staining.

This case uses a formaldehyde-free triazine carbamate crosslinker to form durable, solvent-resistant films in waterborne coatings.

Bis-imidazole-carboxylate reagents stabilize nucleic acids and proteins, then DETA or DTT enables un-fixing before partition-based analysis.

This case uses carbazole and nitrile groups in phosphorescent OLED hosts to lower voltage, raise efficiency, and extend lifetime.

This case develops defined small molecules that target STAT6 activity, supporting selective inhibition for allergic and inflammatory diseases.

This case uses a fused naphthobenzofuran core to improve hole transport, light efficiency, thermal stability, and OLED service life.

A cyclic α-N-protected amino ester and amine catalyst produce diketopiperazines with up to 100% yield and 90% purity.

Reactive benzotriazole groups polymerize into eye-device films, extending absorption to 380–460 nm and limiting absorber migration.

New lipid structures form nucleic acid complexes for simpler, more stable delivery into diverse cells and tissues.

Bicyclic heteroaryl compounds selectively degrade IKZF2 in Tregs to enhance effector T cell function and reduce toxicity.

Defined TYK2 inhibitor polymorphs use controlled crystallization to improve aqueous solubility, stability, purity, and bioavailability.

Mixed hole transport compounds reduce interface thermal degradation and extend device life.

Azeotropic HCFO-1233yd(Z) and tDCE compositions support nonflammable cleaning and heat transfer without major composition change.

Defined substituent patterns tune HIF-2α inhibition, selectivity, and pharmacokinetic behavior for cancer and inflammatory disorders.

This apixaban process combines potassium carbonate catalysis, amidation, and controlled crystallization for high-purity scale-up.

Asymmetric spirocyclic cycloalkyne derivatives promote single-regioisomer SPAAC for efficient peptide-drug conjugation and purification.

Formula (I) compounds selectively block hT2R54 signaling to reduce bitter taste in foods and medicinal compositions.

Sorafelogs target kinase pathways while reducing toxicity and resistance.

A cyclodextrin inclusion complex protects an unstable chemotherapeutic agent in aqueous solution while preserving IV therapeutic use.

This OLED case uses ohmic contact, low-mobility layers, and material segmentation to balance carriers and reduce driving voltage.

This case develops a tricyclic heterocyclic carbaldehyde compound to inhibit IRE1α in cancers including aggressive breast cancer.

This case uses sulfo-containing MOF catalysts to isomerize BPA by-products, improving selectivity while limiting coking and pore blockage.

Fluorescence quenching uses a tracer and binding partner to measure analyte concentration without separation, simplifying immunoassays.

Substituted pyrrolidine amides tune glucocorticoid receptor activity and reduce metabolic and muscle-related adverse effects.

Catechol-functionalized polymer arms improve hydrogel adhesion and water resistance.

This case tunes indolonaphthopyran substituents by steric bulk and Hammett values to improve bleach color and lens clarity.

Fused heteroaryl compounds target sodium channel subtypes while limiting off-target effects.

Zwitterionic amine derivatives broaden buffering from pH 2–12, reduce chelation, and support protein stability and process yields.

These pyrido-pyrimidinone and pteridinone compounds inhibit IRE1α while balancing potency, selectivity, and pharmacological properties.

Speaker identification processing attributes messages to individual user accounts, resolving confusion from misidentified senders in multi-user shared devices.

A centrally-substituted tetraene group enables functionalization of living cationic polymers via bi-directional initiators.

Donor and acceptor units linked by non-conjugated bridges reduce singlet-triplet energy gaps, improving emission efficiency in optoelectronic devices.

A pyrazolo[5,1-a]isoquinoline heterocyclic compound enhances hole transfer efficiency in organic light-emitting devices.

A crystalline epoxy resin compound with a mesogen structure enhances thermal conductivity in insulating materials.

Water extractive distillation purifies propylene oxide while minimizing yield loss to glycols.

Compounds reduce glucose availability to cancer cells, addressing insufficient inhibition of existing treatments while sparing normal cell function.

A novel polycyclic fused aryl compound enhances electron injection in organic electroluminescence devices.

Bifunctional compounds degrade the PXR nuclear receptor via the ubiquitin-proteasome pathway, sensitizing cancer stem cells to chemotherapy.

Substituted bicyclo[4.1.0]heptane amides intensify umami taste and mouthfeel in food products.

Chiral borane reagents reduce alpha-haloketones to diastereoisomerically pure intermediates, eliminating chromatographic separation of stereoisomers.

Silver ion extraction separates FK506 from saturated analogs, reducing purification time and costs compared to column chromatography.

Specific structural features at defined positions create localized interaction zones that enhance selective binding to USP7 while minimizing off-target effects.

Cyclobutoxy compounds act as histamine H3 receptor ligands, reducing side effects from off-target binding.

Novel triazine derivatives antagonize P2X3 receptors, addressing insufficient analgesic benefits in current chronic pain treatments.

Tetrazole polyols react with isocyanate resins to create stable energetic binders, replacing unstable organic azides.

Ethanolamine reactor couples exothermic and endothermic reactions, eliminating separate heating requirements to conserve energy during joint production.

1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives modulate the CXCR3 receptor to treat autoimmune disorders.

Isobaric aldehyde-reactive tags enable precise glycan quantification via reductive amination and tandem mass spectrometry.

Segmenting kinase inhibition from bromodomain targeting reduces side effects while maintaining therapeutic effectiveness.

Mixed solvent system partitions propylene oxide into organic phase, reducing methanol usage and energy consumption for purification.

Optimized reaction conditions remove chromatographic purification steps, achieving high enantiomeric purity while maintaining manufacturing efficiency.

Selective adsorption removes sorbitans from isosorbide, avoiding complex distillation.

Inert environment-resistant polymer structures maintain electrical stability in ambient air, eliminating costly oxygen exclusion during manufacturing.

A polysulfonate-based additive forms a stable passivation film on the negative electrode to maintain battery capacity.

Formula I compounds labeled with radionuclides detect early abnormalities to support targeted therapeutic strategies.

A one-pot process synthesizes N-substituted phenyl-5-hydroxymethyl-2-oxazolidinone using epichlorohydrin and aniline under alkaline conditions.

Cationic memantine derivatives block peripheral NMDA receptors, reducing pulmonary vascular remodeling without central nervous system side effects.

A press device extracts chemical compounds from plant material using a carrier oil mixture.

A novel hole transport compound enhances OLED light efficiency and lifespan through optimized energy level alignment.

Polycyclic diiminooxadiazinones provide latent crosslinking capability through cyclized structures.

Inverting ester bonds to pendant side chains protects crosslinking integrity from hydrolytic cleavage, extending polymer longevity.

Liquid oxazolidine curing agents with modified ring structures enable stable storage and rapid crosslinking in polyurethane systems.

Cabozantinib metabolites with glucuronic acid moieties maintain anticancer efficacy while reducing toxicity via parameter changes.

Lewis acids enable selective protection and acylation of baccatin derivatives, resolving low yield and complex purification bottlenecks in taxoid manufacturing.

Meta-linked triarylamine molecules enable balanced charge transport, resolving interface degradation and extending device lifetime.

Replacing trifluoroacetic acid with disposable carboxylic acids eliminates vessel corrosion and oxidant degradation during fipronil synthesis.

Segmented mechanical power input controls carbonate particle morphology, resolving energy density limitations in lithium ion battery cathode materials.

Indeno fused phenanthrenopyran compounds with lengthening groups increase optical density and sensitivity in high-molecular matrices.

Wax-modified hyperbranched polyols enable low VOC coating formulations while maintaining flexibility and durability at low temperatures.

A pigment dispersion uses a polyamine-polyester graft copolymer to stabilize fine particles.

Peroxide-induced radical addition alters triglyceride viscosity while resolving oxidation susceptibility in renewable lubricants.

Composite low molecular weight and polymer materials resolve film quality versus processability trade-offs.

Incorporating carbazole or fluorene structures in the anode-side layer reduces the initial luminance drop during constant current drive.

Modified polyphenol structures improve potency and pharmacokinetic profiles to treat diseases linked to electron transfer chain modification.

Palladium catalyzed intramolecular alkenylation constructs benzofuranone spirocycles with high diastereoselectivity.

Selective macrocyclic factor XIa inhibitors resolve narrow therapeutic index and monitoring requirements of warfarin.